Rational peptide selection to detect human immunodeficiency virus type 1-specific T-cell responses under

C B Willberg1, S K Pillai, E R Sharp

  • 1Division of Experimental Medicine, Department of Medicine, UCSF, San Francisco, CA 94158, USA.

Summary

Developing new human immunodeficiency virus type 1 (HIV-1) vaccines and therapies requires understanding T-cell responses. A novel peptide selection method targets stable HIV-1 genome regions, aiding research in resource-limited settings.

Related Concept Videos